circSLC30A7 Inhibits Hepatocellular Carcinoma Cell Proliferation via the miR-767-5p/FBXW7/NOTCH1 Axis

Table 1

The relationship between the expression of circSLC30A7 and the clinical characteristics of HCC patients.

Characteristics	Number	circSLC30A7 expression		P value
		High group	Low group
Age (years)
<60	14	5	9	0.207
≥60	36	20	16
Gender
Male	27	13	14	0.776
Female	23	12	11
Size (cm)
<5	23	15	8	0.047
≥5	27	10	17
Stage
I/II	21	14	7	0.044
III/IV	29	11	18
Differentiation grade
Well + moderate	26	13	13	0.999
Poor	24	12	12
Metastasis
Absent	28	15	13	0.568
Present	22	10	12

, statistically significant difference.